These data suggest that dynorphin action is at least partially mediated by the hypothalamo-pituitary-thyrotropic and -somatotropic axes.In summary, these data indicate that one or more dynorphin opioids are involved in regulating at least the following factors involved in obesity and its complications such as type II diabetes, and the management thereof: (i) the modulation of starvation responses